StockOtters
StockOttersSupply Chain Map
Bio-Rad Laboratories, Inc. logo

Bio-Rad Laboratories, Inc.

BIO

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
2,567
Cost of Revenue
1,188
Gross Profit
1,379
Gross Margin
53.7%
Operating Income
269
Operating Margin
10.5%
Net Income
-1,844
Net Margin
-71.9%
EPS (Basic)
$-65.36
EPS (Diluted)
$-65.36
EBITDA
-2,142
EBITDA Margin
-83.5%

2023

12/31/2023

Revenue
2,671
Cost of Revenue
1,244
Gross Profit
1,427
Gross Margin
53.4%
Operating Income
338
Operating Margin
12.6%
Net Income
-637
Net Margin
-23.9%
EPS (Basic)
$-21.82
EPS (Diluted)
$-21.82
EBITDA
-655
EBITDA Margin
-24.5%

2022

12/31/2022

Revenue
2,802
Cost of Revenue
1,235
Gross Profit
1,567
Gross Margin
55.9%
Operating Income
483
Operating Margin
17.2%
Net Income
-3,628
Net Margin
-129.5%
EPS (Basic)
$-121.79
EPS (Diluted)
$-121.79
EBITDA
-4,489
EBITDA Margin
-160.2%

2021

12/31/2021

Revenue
2,923
Cost of Revenue
1,284
Gross Profit
1,638
Gross Margin
56.1%
Operating Income
500
Operating Margin
17.1%
Net Income
4,254
Net Margin
145.6%
EPS (Basic)
$142.61
EPS (Diluted)
$140.83
EBITDA
5,588
EBITDA Margin
191.2%

2020

12/31/2020

Revenue
2,546
Cost of Revenue
1,108
Gross Profit
1,438
Gross Margin
56.5%
Operating Income
421
Operating Margin
16.6%
Net Income
3,814
Net Margin
149.8%
EPS (Basic)
$127.86
EPS (Diluted)
$126.20
EBITDA
5,078
EBITDA Margin
199.5%